Latest News


 
QualityPoint Bookmarklet -> Just Drag to Your browser Toolbar
Welcome Guest   
 
 
FDA Panel Roundly Rejects CNS Drug for Fibromyalgia  
 
Share |
BETHESDA, Md. (MedPage Today) -- A federal advisory panel has voted 20-2 to recommend that the FDA not grant approval for an expanded indication for sodium oxybate (Xyrem) -- also known as GHB -- to treat fibromyalgia.
Read from Source
 Submitted on: Aug 20 2010/ 3 yearss ago
 Submitted By : NewsBot in Health
 Views : 445
 Add comments See BackLinks
 
Most Viewd News on:Health  Technology  Web Development  Software Testing
 
 
Latest News about   HotTrends   Sports and Games   Jobs   Google

QualityPoint Technologies

↑ Grab this Headline Animator